Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia
Transfusion, 06/20/2012
Loewenthal R et al. – The authors suggest that a specific genotyping of the mother in relation to human leukocyte antigens (HLAs)–DRB as well as human PLT antigen (HPA)–1 can serve as an antenatal diagnostic tool, particularly in siblings of women who gave birth to neonates with Fetal neonatal alloimmune thrombocytopenia (FNAIT).



